Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

People with alopecia areata have higher insulin resistance.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Hydroxychloroquine may help treat alopecia areata in children.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Tamoxifen caused hair loss in a 52-year-old woman.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Hair transplantation can effectively treat stable eyebrow hair loss in alopecia areata patients.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Temporary hair loss can occur after brain AVM treatment but usually regrows in 8 weeks.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

Injections with 0.5% minoxidil effectively treat female hair loss, increasing hair density and thickness.